BrainStorm Cell Therapeutics Inc (BCLI) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Summary

BrainStorm Cell Therapeutics Inc (BrainStorm Cell Therapeutics) formerly Golden Hand Resources Inc is a biotechnology company which develops autologous stem cell therapies for neurodegenerative diseases. Its pipeline mesenchymal stem cell products are being developed based on cell therapy platform NurOwn, customized for the treatment of multiple sclerosis, amyotrophic lateral sclerosis, parkinsons disease, huntingtons disease, autism spectrum disorder, peripheral nerve injury, and other indications. Its proprietary technology NurOwn induces mesenchymal stem cells to secrete high levels of neurotrophic factors to promote the survival of neurons. The company has operations in the US and Israel. BrainStorm Cell Therapeutics is headquartered in New York, the US.

BrainStorm Cell Therapeutics Inc (BCLI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

It derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.



List of Tables 4
List of Figures 4
BrainStorm Cell Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BrainStorm Cell Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
BrainStorm Cell Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BrainStorm Cell Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
BrainStorm Cell Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 9
BrainStorm Cell Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
BrainStorm Cell Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
BrainStorm Cell Therapeutics Enters into Agreement with University of California Irvine Medical Center 11
BrainStorm Cell Therapeutics Enters into Agreement with Massachusetts General Hospital and California Pacific Medical Center 12
BrainStorm Cell Therapeutics Enters into Partnership with Hadassah Medical Center 13
Equity Offering 14
BrainStorm Cell Therapeutics Plans to Raise USD100 Million in Public Offering of Securities 14
BrainStorm Cell Therapeutics Raises USD12.3 Million in Private Placement of Shares upon Exercise of Warrants 15
BrainStorm Cell Therapeutics Raises USD13 Million Through Exercise of Warrants 16
BrainStorm Cell Therapeutics Raises USD3.1 Million upon Exercise of Warrants 17
BrainStorm Cell Therapeutics Raises USD10.5 Million in Private Placement of Shares 18
BrainStorm Cell Therapeutics Completes Public Offering Of Units For US$4 Million 19
BrainStorm Cell Therapeutics Completes Private Placement Of Shares For US$0.25 Million 20
BrainStorm Cell Therapeutics Raises Funds in Private Placement of Units 21
BrainStorm Cell Therapeutics Completes Public Offering Of Shares For US$5.8 Million 22
BrainStorm Cell Therapeutics Inc - Key Competitors 23
BrainStorm Cell Therapeutics Inc - Key Employees 24
BrainStorm Cell Therapeutics Inc - Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Recent Developments 26
Financial Announcements 26
May 14, 2018: BrainStorm Announces First Quarter 2018 Financial Results and Provides Corporate and Clinical Highlights 26
Mar 08, 2018: BrainStorm Announces Operational Highlights and Financial Results for the Year Ended December 31, 2017 28
Oct 17, 2017: BrainStorm Announces Third Quarter 2017 Financial Results 29
Aug 14, 2017: BrainStorm Announces Second Quarter 2017 Financial Results 30
May 15, 2017: BrainStorm Announces First Quarter 2017 Financial Results and Provides Corporate Update 31
Mar 30, 2017: BrainStorm Announces Financial Results for 2016 and Provides Business Update 33
Corporate Communications 35
Nov 02, 2017: BrainStorm Strengthens Executive Team: Appoints Eyal Rubin as Chief Financial Officer 35
Mar 06, 2017: BrainStorm Strengthens Management Team with Appointment of Ralph Z. Kern, MD, MHSc as Chief Operating Officer and Chief Medical Officer 36
Other Significant Developments 37
Feb 14, 2018: The Alliance for Regenerative Medicine Announces Initial Slate of Presenting Companies at the Sixth Annual Cell & Gene Therapy Investor Day 37
Appendix 38
Methodology 38
About GlobalData 38
Contact Us 38
Disclaimer 38

List Of Tables

List of Tables
BrainStorm Cell Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
BrainStorm Cell Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BrainStorm Cell Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
BrainStorm Cell Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BrainStorm Cell Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 8
BrainStorm Cell Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 9
BrainStorm Cell Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
BrainStorm Cell Therapeutics Enters into Agreement with University of California Irvine Medical Center 11
BrainStorm Cell Therapeutics Enters into Agreement with Massachusetts General Hospital and California Pacific Medical Center 12
BrainStorm Cell Therapeutics Enters into Partnership with Hadassah Medical Center 13
BrainStorm Cell Therapeutics Plans to Raise USD100 Million in Public Offering of Securities 14
BrainStorm Cell Therapeutics Raises USD12.3 Million in Private Placement of Shares upon Exercise of Warrants 15
BrainStorm Cell Therapeutics Raises USD13 Million Through Exercise of Warrants 16
BrainStorm Cell Therapeutics Raises USD3.1 Million upon Exercise of Warrants 17
BrainStorm Cell Therapeutics Raises USD10.5 Million in Private Placement of Shares 18
BrainStorm Cell Therapeutics Completes Public Offering Of Units For US$4 Million 19
BrainStorm Cell Therapeutics Completes Private Placement Of Shares For US$0.25 Million 20
BrainStorm Cell Therapeutics Raises Funds in Private Placement of Units 21
BrainStorm Cell Therapeutics Completes Public Offering Of Shares For US$5.8 Million 22
BrainStorm Cell Therapeutics Inc, Key Competitors 23
BrainStorm Cell Therapeutics Inc, Key Employees 24
BrainStorm Cell Therapeutics Inc, Other Locations 25
BrainStorm Cell Therapeutics Inc, Subsidiaries 25

List Of Figures

List of Figures
BrainStorm Cell Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
BrainStorm Cell Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
BrainStorm Cell Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
BrainStorm Cell Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
BrainStorm Cell Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BrainStorm Cell Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
BrainStorm Cell Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BrainStorm Cell Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
BrainStorm Cell Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 9

BrainStorm Cell Therapeutics Inc (BCLI) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

BrainStorm Cell Therapeutics Inc (BrainStorm Cell Therapeutics) formerly Golden Hand Resources Inc is a biotechnology company which develops autologous stem cell therapies for neurodegenerative diseases. Its pipeline mesenchymal stem cell

USD 250 View Report

Brainstorm Cell Therapeutics Inc Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

Brainstorm Cell Therapeutics Inc Company Profile is a detailed strategic and analytical report on Brainstorm Cell Therapeutics Inc. The 2018 version of the report offers detailed insights into the companys

USD 200 View Report

Asia Pacific Natural Killer (NK) Cell Therapeutics Market Report (2014-2024) - Market Size, Share, Price, Trend and Forecast

Abstract:The Asia Pacific Natural Killer (NK) Cell Therapeutics market size is $XX million USD in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX

USD 3000 View Report

Europe Natural Killer (NK) Cell Therapeutics Market Report (2014-2024) - Market Size, Share, Price, Trend and Forecast

Abstract:The Europe Natural Killer (NK) Cell Therapeutics market size is $XX million USD in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million

USD 3000 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available